CD8A and cancer: Our study demonstrates a positive association between NRAV and various immune cell types, including B cells, CD4+ T cells, CD8+ T cells, neutrophils, macrophages, and DC cells, in multiple cancer types such as KIRC, LGG, PRAD, LIHC, USC, GBMLGG, KICH, and DLBC.